Cingulate Inc. (CING)
NASDAQ: CING · Real-Time Price · USD
5.66
+0.49 (9.48%)
At close: Jul 21, 2025, 4:00 PM
5.75
+0.09 (1.59%)
Pre-market: Jul 22, 2025, 8:05 AM EDT
Cingulate Market Cap
Cingulate has a market cap or net worth of $24.03 million as of July 22, 2025. Its market cap has increased by 888.90% in one year.
Market Cap
24.03M
Enterprise Value
19.59M
1-Year Change
888.90%
Ranking
Category
Stock Price
$5.66
Market Cap Chart
Since the IPO on December 8, 2021, Cingulate's market cap has decreased from $64.29M to $24.03M, a decrease of -62.62%. That is a compound annual growth rate of -23.85%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 18, 2025 | 21.95M | 34.85% |
| Dec 31, 2024 | 16.28M | 127.09% |
| Dec 29, 2023 | 7.17M | -36.62% |
| Dec 30, 2022 | 11.31M | -63.77% |
| Dec 31, 2021 | 31.21M | -51.44% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 692.79B |
| Johnson & Johnson | 393.87B |
| AbbVie | 334.31B |
| Novo Nordisk | 287.38B |
| UnitedHealth Group | 256.40B |
| Novartis AG | 223.49B |
| Abbott Laboratories | 215.17B |
| AstraZeneca | 214.61B |